6 Allergy Headlines You Missed in July 2025

Several key studies and recommendations signaled meaningful shifts in clinical practice for the allergy field. From the US Food and Drug Administration (FDA) approval of sebetralstat (Ekterly) as the first oral, on-demand treatment for hereditary angioedema (HAE) to new data supporting donidalorsen’s efficacy in patients switching from other prophylactics, therapeutic options continue to expand.